Medline dips as PE backers trim stakes in $3.1 bln stock sale

Medline

05/03/2026 12:55

** Medline's MDLN.O shares down 1.9% premarket at $42.08 as ~$3.1 bln secondary offering priced just months after medical supplier's Dec public debut

    **
    MDLN late Weds announced sale of 75 mln shares by Blackstone BX.N, Carlyle CG.O, Hellman & Friedman (H&F) and Abu Dhabi Investment Authority (ADIA) at $41

    ** Offering price represents 4.4% discount to stock's last close of $42.88

    ** MDLN's stock closed at $45.85 on Mon, prior to offering launch early Tues, having surged 58% since co's $7.2 bln IPO (inclusive of full overallotment), 2025's largest

    ** Private equity backers BX, CG and H&F offloaded 23.3 mln shares each, ADIA sold 5.1 mln shares, per the offering prospectus

    ** Northfield, Illinois-based MDLN has ~1.3 bln shares outstanding

    ** Goldman Sachs, Morgan Stanley, BofA and JP Morgan global coordinators and joint bookrunners for offering

    ** 20 of 25 analysts rate the stock "strong buy" or "buy", rest "hold"; median PT $55, per latest LSEG data

(Lance Tupper is a Reuters market analyst. The views expressed are his own)

((lance.tupper@tr.com 1-646-279-6380))